When a man receives a prostate cancer diagnosis, thoughts often race toward treatment options and survival rates. However, the recovery journey after prostate surgery represents a critical chapter ...

The most common surgery for prostate cancer is a radical prostatectomy. This surgery involves taking out the entire prostate gland, some lymph nodes and other nearby tissue, like the seminal vesicles ...

A technique to improve the precision of prostate cancer surgery means that almost twice as many men preserve their erectile function compared to those undergoing standard surgery, according to results ...

Thanks to early detection and aggressive treatment for prostate cancer, 97 percent of all men diagnosed with the disease will survive at least 5 years and nearly 80 percent will survive at least a ...

Results from a phase 3 clinical trial, recently published in The Lancet Oncology, present a significant breakthrough in the field of prostate cancer surgery. The NeuroSAFE technique, a novel approach ...

A nerve-sparing technique (NeuroSAFE) reduced erectile dysfunction in men undergoing robot-assisted radical prostatectomy (RARP) for prostate cancer. A year after surgery, patients randomized to ...

of erectile function 1 year after surgery is associated with higher technical skills and increased use of specific surgical gestures by the operating surgeon. The findings were published in JAMA ...

This post has been a year in the making. I’ve wanted to share what our experience has been like but I wanted to be sure I waited long enough to give a comprehensive account of what this has been like ...

R&B star and local pastor Montell Jordan shared joyful news with fans, announcing that he is officially cancer free after a ...

A BREAKTHROUGH IN PROSTATE CANCER TREATMENT IS NOW AVAILABLE RIGHT HERE IN CINCINNATI, AND ONE LOCAL HOSPITAL AND DOCTOR ARE UTILIZING IT WITH EARLY SUCCESS. WLWT NEWS FIVE’S MEGAN MITCHELL SPOKE WITH ...

Prostatectomy and radiation therapy show no survival difference for low-risk prostate cancer, but higher-risk cases require careful treatment consideration. The ProtecT trial supports active ...